NEWS: 公告在東京證券交易所JASDAQ標準市場新上市



Global Smart Syringes Market - Forecasts from 2021 to 2026

出版商 Knowledge Sourcing Intelligence 商品編碼 1023164
出版日期 內容資訊 英文 115 Pages
商品交期: 最快1-2個工作天內
全球智慧注射器市場-預測(2021年∼2026年) Global Smart Syringes Market - Forecasts from 2021 to 2026
出版日期: 2021年07月09日內容資訊: 英文 115 Pages





第1章 簡介

  • 市場定義
  • 市場區隔

第2章 調查手法

  • 調查資料
  • 假設

第3章 摘要整理

  • 調查的重點

第4章 市場動態

  • 市場推動要素
  • 市場阻礙因素
  • 波特五力分析
    • 供給企業談判力
    • 買方議價能力
    • 新加入廠商的威脅
    • 替代品的威脅
    • 產業的競爭間的競爭
  • 產業的價值鏈分析

第5章 各類型智慧注射器市場分析

  • 簡介
  • 自動無效的注射器
  • 主動式安全性注射器
  • 被動式安全性注射器

第6章 各應用領域智慧注射器市場分析

  • 簡介
  • 疫苗接種
  • 藥物運輸
  • 體液採取

第7章 各終端用戶智慧注射器市場分析

  • 簡介
  • 醫院及診療所
  • 門診病人診療中心

第8章 各地區智慧注射器市場分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 法國
    • 德國
    • 義大利
    • 其他
  • 中東和非洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 泰國
    • 台灣
    • 印尼
    • 其他

第9章 競爭環境與分析

  • 主要業者與策略分析
  • 新興參與者和市場收益性
  • 合併,收購,協定,及合作
  • 供應商競爭力的矩陣

第10章 企業簡介

  • BD
  • PAL System
  • VOGT Medical
  • L.O.M. Medical International
  • Credence MedSystems Inc.
  • Retractable Technologies Inc.
  • Dali Medical Devices
  • AlShifa Medical Products
  • Advacare Pharma USA
Product Code: KSI061611611

The global smart syringes market is expected to grow at a compound annual growth rate of 13.77% over the forecast period to reach a market size of US$17.123 billion in 2026 from US$6.940 billion in 2019.

Smart syringes are engineered in such a way that prevents their reutilization, thus, regulating unsafe injection practices. These syringes cater to a wide range of applications including vaccination, drug delivery, and body fluid specimen collection. The rise in the incidences of diseases such as HIV, Hepatitis C, and other infections due to unsafe injection practices is driving the market for smart syringes. Major companies have been making significant developments in the market, in the past few years. For instance, PAL Systems, one of the key players in the market, provides a smart syringe that contains electronic data storage for process safety and the highest precision. The company's consistent quality of every syringe had been guaranteed by CTC Analytics. Other players have also been making a considerable impact in the market. AccPoint, a division of AdvaCare Pharma USA, provides auto-disable syringes, which had been made of a plethora of materials, and medical-grade PVC for the plunger and barrel, that ensures reliability regarding the precision needle and syringe's seal.

Impact of COVID-19 Pandemic.

The COVID-19 pandemic had been expected to accelerate the demand for smart syringes, because of the rise in the covid vaccination process. Countries, worldwide, have been spending a significant sum of capital to purchase vaccines and medical equipment, to vaccinate their population. Major companies have been making a significant impact in the market. For instance, in June 2021, IHDLife, one of the key players in the market, announced that it had been shipping two million auto-disable syringes to the United States government, intending to ensure vaccination against the covid virus. There are other developments in the market. For instance, in November 2020, Hindustan Syringes & Medical Devices Ltd., announced that it had shipped over 100 million pieces of KOJAK auto-disable syringes to COVAX, the global vaccination organization's stockpile facility. The company had also stated that they had been planning to allocate 50% of the total 0.5 ML auto-disable syringes for export and the rest 50% for the government of India. In February 2021, UNICEF announced that it had sent 100,000 syringes to the Maldives for COVID-19 vaccination. The organization had also stated that they would ship over 14.5 million auto-disable syringes to more than 30 nations, globally. been These trends are expected to have a positive impact on the market, in the coming period.

Latest Developments.

  • In June 2021, The Odisha Drug Controller Directorate in India had announced that it had given Nobel Pharmacare Limited the license to produce and manufacture 0.5 ml Auto Disable syringes. This development is expected to have a positive impact on the market, in the coming years.
  • In January 2021, The Hindustan Syringes and Medical Devices announced that it had received the WHO-performance, quality, and safety certification for its major flagship 0.3 ML KOJAK auto-disposal syringes. The company had stated that these syringes would be required for Pfizer's Corona vaccine. The company had also been accelerating its production capacity to manufacture a 0.5 ML auto disposal syringe.
  • In December 2020, Becton, Dickinson and Company, a key player in the market, announced that it had been planning to invest around US$1.2 billion over the next years to upgrade and expand manufacturing technology and capacity for advanced drug delivery systems and pre-fillable syringes, across its six major manufacturing locations. The company had also been planning to add a novel production facility in Europe.

Increasing cases of Hepatitis.

Hepatitis is known as an inflammation of the liver that causes a wider range of health problems. There are mainly five strains of the hepatitis virus, which are referred to as A, B, C, D, and E. According to the World Health Organization, an estimated number of 325 million people, globally, live with hepatitis type B or C. The WHO had stated that around 7,134 deaths, globally, had been due to hepatitis A, in the year 2016. In the year 2019, over 250 million were living with chronic hepatitis B infection. Globally, around 71 million people have been living with chronic hepatitis C virus infection. The increasing rate of hepatitis virus is expected to accelerate the demand for smart syringes, globally. Millions of people, worldwide, could be protected from certain infections caused due to unsafe and lower quality injections. The World Health Organization had recommended that there should be an acceleration in the adoption of smart syringes, that cannot be used more than once. The International Health Body had also launched a policy of global and injection safety with the support from some of the reputed organizations, such as the Vaccine Alliance, IKEA Foundation, and Gavi. These trends are expected to have a positive impact on the market, in the coming years.

Market Segmentation:

  • By Type
  • Auto-disable syringe
  • Active safety syringes
  • Passive safety syringes
  • By Application
  • Vaccination
  • Drug delivery
  • Body Fluid Sample Collection
  • By End Users
  • Hospitals and Clinics
  • Ambulatory Care Centers
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Thailand
  • Taiwan
  • Indonesia
  • Others

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. Smart Syringe Market Analysis, By Type

  • 5.1. Introduction
  • 5.2. Auto-disable syringe
  • 5.3. Active safety syringes
  • 5.4. Passive safety syringes

6. Smart Syringe Market Analysis, By Application

  • 6.1. Introduction
  • 6.2. Vaccination
  • 6.3. Drug delivery
  • 6.4. Body Fluid Sample Collection

7. Smart Syringe Market Analysis, By End Users

  • 7.1. Introduction
  • 7.2. Hospitals and Clinics
  • 7.3. Ambulatory Care Centers

8. Smart Syringe Market Analysis, By Geography

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. UK
    • 8.4.2. France
    • 8.4.3. Germany
    • 8.4.4. Italy
    • 8.4.5. Others
  • 8.5. Middle East and Africa
  • 8.6. Asia Pacific
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. Thailand
    • 8.6.5. Taiwan
    • 8.6.6. Indonesia
    • 8.6.7. Others

9. Competitive Environment and Analysis

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Emerging Players and Market Lucrativeness
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Vendor Competitiveness Matrix

10. Company Profiles

  • 10.1. BD
  • 10.2. PAL System
  • 10.3. VOGT Medical
  • 10.4. L.O.M. Medical International
  • 10.5. Credence MedSystems Inc.
  • 10.6. Retractable Technologies Inc.
  • 10.7. PRICON
  • 10.8. Dali Medical Devices
  • 10.9. AlShifa Medical Products
  • 10.10. Advacare Pharma USA